WHO informal consultation on the scientific basis of specifications for production and control of inactivated Japanese encephalitis vaccines for human use, Geneva, Switzerland, 1-2 June 2006

Vaccine

Volumn 25, Issue 29, 2007, Pages 5233-5243

  Ferguson, Morag ^a   Kurane, Ichiro ^b   Wimalaratne, Omala ^c   Shin, Jinho ^d   Wood, David ^d  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c Medical Research Institute Colombo   (Sri Lanka)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Japanese encephalitis; Viral vaccine; World Health Organization

Indexed keywords

JAPANESE ENCEPHALITIS VACCINE;

CELL CULTURE; CLINICAL TRIAL; CONFERENCE PAPER; CONSULTATION; DRUG MANUFACTURE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG TOLERABILITY; ENCEPHALOMYELITIS; EPIDEMIC ENCEPHALITIS; EVALUATION; FEVER; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; POSTINFECTION ENCEPHALITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; STANDARD; STANDARDIZATION; VERO CELL; WORLD HEALTH ORGANIZATION;

ANIMALS; CERCOPITHECUS AETHIOPS; ENCEPHALITIS, JAPANESE; HUMANS; JAPANESE ENCEPHALITIS VACCINES; MICE; SWITZERLAND; VERO CELLS; VIRAL VACCINES; WORLD HEALTH ORGANIZATION;

EID: 34250799651     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.05.034     Document Type: Conference Paper

References (19)

1. World Health Organization. Japanese encephalitis vaccines: WHO position paper. Weekly Epidemiol Rec 81 (2006) 331-340
2. World Health Organization. Report of the bi-regional meeting on Japanese encephalitis (WHO SEA/WPR and PATH's JE Project). New Delhi, India, 2005.
3. Tsai TF. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, October 13-15, 1998. Vaccine 2000;18 Suppl 2:1-25.
4. Igarashi A. Epidemiology and control of Japanese encephalitis. World Health Stat Q 45 2/3 (1992) 299-305
5. Luo D., Yin H., Xili L., Song J., and Wang Z. The efficacy of Japanese encephalitis vaccine in Henan, China: a case-control study. Southeast Asian J Trop Med Public Health 25 4 (1994) 643-646
6. Ding D., Kilgore P.E., Clemens J.D., Wei L., and Zhi-Yi X. Cost-effectiveness of routine immunization to control Japanese encephalitis in Shanghai, China. Bull World Health Organ 81 5 (2003) 334-342
7. Siraprapasiri T., Sawaddiwudhipong W., and Rojanasuphot S. Cost benefit analysis of Japanese encephalitis vaccination program in Thailand. Southeast Asian J Trop Med Public Health 28 1 (1997) 143-148
8. World Health Organization. Requirements for Japanese encephalitis vaccine (inactivated) for human use. In: WHO Expert Committee on Biological Standardization, vol. Thirty-eighth report. Geneva: World Health Organization; 1988.
9. Hombach J, Solomon T, Kurane I, Jacobson J, Wood D. Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, September 2-3, 2004. Vaccine 2005;23(45):5205-11.
10. World Health Organization. Guidelines on transmissible spongiform encephalopathies in relation to biological and pharmaceutical products. WHO Expert Committee on Biological Standardization (2003), World Health Organization, Geneva
11. World Health Organization. Procedure for assessing the acceptability, in principle, of vaccines for purchase by United Nations agencies. WHO/IVB/05.19. http://www.who.int/vaccines-documents/DocsPDF06/812.pdf. 2006.
12. World Health Organization. National regulatory authorities. http://www.who.int/immunization_standards/national_regulatory_authorities%20/role/en/index.html/. accessed May 1, 2007.
13. World Health Organization. Developing Countries' Vaccine Regulators Network Establishment. http://www.who.int/immunization_standards/vaccine_regulation/dcvrn/en/index.html/. accessed May 1, 2007.
14. World Health Organization. Global Advisory Committee on Vaccine Safety (GACVS). http://www.who.int/vaccine_safety/en/. accessed May 1, 2007.
15. World Health Organization. Guidelines for the production and control of Japanese encephalitis vaccine (live) for human use. In: WHO Expert Committee on Biological Standardization vol. Fifty-first report. Geneva: World Health Organization; 2002.
16. World Health Organization. Requirements for the use of animal cells as in vitro substrates for the production of biologicals (requirements for biological substances no. 50). In: WHO Expert Committee on Biological Standardization vol. Forty-seventh report. Geneva: World Health Organization; 1998.
17. World Health Organization. Requirements for the use of animal cells as in vitro substrates for the production of biologicals (addendum 2003). In: WHO Expert Committee on Biological Standardization vol. Fifty-fourth report. Geneva: World Health Organization; 2005.
18. Hoke C.H., Nisalak A., Sangawhipa N., Jatanasen S., Laorakapongse T., Innis B.L., et al. Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med 319 10 (1988) 608-614
19. Hammon W.M., and Sather G.E. Passive immunity for arbovirus infection. I. Artificially induced prophylaxis in man and mouse for Japanese (B) encephalitis. Am J Trop Med Hyg 22 4 (1973) 524-534